Mangalam Drugs & Organics Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 929.008 million compared to INR 885.479 million a year ago. Net income was INR 21.542 million compared to INR 50.54 million a year ago. Basic earnings per share from continuing operations was INR 1.36 compared to INR 3.19 a year ago. For the full year, total revenue was INR 3,848.612 million compared to INR 2,835.348 million a year ago. Net income was INR 279.709 million compared to INR 82.525 million a year ago. Basic earnings per share from continuing operations was INR 17.67 compared to INR 5.21 a year ago.